Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study-Reference-Cited by-同舟云学术

Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study

Published:2010-01 Issue:1 Volume:11 Page:48-54
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Zhu Andrew X,Meyerhardt Jeffrey A,Blaszkowsky Lawrence S,Kambadakone Avinash R,Muzikansky Alona,Zheng Hui,Clark Jeffrey W,Abrams Thomas A,Chan Jennifer A,Enzinger Peter C,Bhargava Pankaj,Kwak Eunice L,Allen Jill N,Jain Sanjay R,Stuart Keith,Horgan Kerry,Sheehan Susan,Fuchs Charles S,Ryan David P,Sahani Dushyant V

Publisher

Elsevier BV

Subject

Oncology

Reference36 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. The epidemiology of cholangiocarcinoma;Shaib;Semin Liver Dis,2004

3. Recent advances in the management of cholangiocarcinomas;Vauthey;Semin Liver Dis,1994

4. Systemic therapy for biliary tract cancers;Hezel;Oncologist,2008

5. Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma;Cho;Cancer,2005

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bevacizumab Erlotinib Switch Maintenance in Chemo-Responsive Advanced Gallbladder and Cholangiocarcinoma (BEER BTC): A Multicenter, Open-Label, Randomized, Phase II Trial;Journal of Clinical Oncology;2024-08-05

2. The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma;Pharmaceuticals;2024-07-08

3. Current and Future Therapeutic Targets for Directed Molecular Therapies in Cholangiocarcinoma;Cancers;2024-04-26

4. Advances in targeted therapy of cholangiocarcinoma;Annals of Medicine;2024-02-15

5. 21Management of Intrahepatic and Extrahepatic Cholangiocarcinoma;Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e;2024-01-23